Research and Development
Petaluma, CA

RetinalGeniX™ Technologies, Inc. is an emerging medical device company focused on commercializing the next generation of cost-effective, ultra-wide imaging technologies to examine the periphery of the retina, at up to a 200° field of view, to detect early signs of diabetic retinopathy and maculopathy without having to dilate a patient's pupil.

There is a dire need for simpler and more affordable devices and methods that allow for uncomplicated but accurate imaging of a person’s retina to detect symptoms of diabetic retinopathy and maculopathy.